Foresite Capital Management VI LLC
24 holdingsFiling period: 2026-06-30Current AUM: $515.1Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | CGON | CG Oncology, Inc. | 2.37M | $168.4M | $145.9M | 28.32% | +148.1K | 2026-06-30 |
| 2 | ALMS | Alumis Inc. | 4.25M | $119.5M | $27.7M | 5.37% | -- | 2026-06-30 |
| 3 | SPTX | Seaport Therapeutics, Inc. | 1.78M | $38.7M | $37.1M | 7.20% | -- | 2026-06-30 |
| 4 | DNLI | Denali Therapeutics Inc. | 1.40M | $35.9M | $26.1M | 5.06% | +186.8K | 2026-06-30 |
| 5 | CLDX | Celldex Therapeutics, Inc. | 879.7K | $32.7M | $26.0M | 5.04% | +563.8K | 2026-06-30 |
| 6 | AGIO | Agios Pharmaceuticals, Inc. | 785.0K | $29.1M | $28.9M | 5.62% | +260.0K | 2026-06-30 |
| 7 | CRVS | Corvus Pharmaceuticals, Inc. | 1.83M | $27.4M | $19.1M | 3.71% | -- | 2026-06-30 |
| 8 | PBLS | Parabilis Medicines, Inc. | 999.0K | $27.3M | $25.0M | 4.85% | -- | 2026-06-30 |
| 9 | — | GH Research PLC | 940.5K | $25.3M | $25.3M | 4.91% | +625.0K | 2026-06-30 |
| 10 | JBIO | Jade Biosciences, Inc. | 886.7K | $19.7M | $12.9M | 2.50% | +566.7K | 2026-06-30 |
| 11 | HNGE | Hinge Health, Inc. | 220.4K | $18.3M | $24.6M | 4.78% | -- | 2026-06-30 |
| 12 | KYMR | Kymera Therapeutics, Inc. | 146.3K | $16.8M | $16.8M | 3.26% | -- | 2026-06-30 |
| 13 | ATAI | AtaiBeckley Inc. | 2.75M | $14.5M | $14.5M | 2.81% | -- | 2026-06-30 |
| 14 | ATAI | AtaiBeckley Inc. | 2.75M | $14.5M | $14.5M | 2.81% | -- | 2026-06-30 |
| 15 | VSTM | Verastem, Inc. | 3.15M | $12.0M | $31.5M | 6.11% | -- | 2026-06-30 |
| 16 | BEAM | Beam Therapeutics Inc. | 330.0K | $11.3M | $7.9M | 1.52% | -- | 2026-06-30 |
| 17 | NERV | Minerva Neurosciences, Inc. | 1.99M | $11.0M | $4.4M | 0.85% | -1,016 | 2026-06-30 |
| 18 | AVBP | ArriVent BioPharma, Inc. | 301.3K | $10.5M | $4.6M | 0.90% | -- | 2026-06-30 |
| 19 | AURA | Aura Biosciences, Inc. | 1.33M | $9.5M | $8.2M | 1.60% | -- | 2026-06-30 |
| 20 | CRNX | Crinetics Pharmaceuticals, Inc. | 212.0K | $7.9M | $7.9M | 1.54% | -- | 2026-06-30 |
| 21 | — | Research Alliance Corp III | 300.0K | $3.2M | $3.2M | 0.62% | -- | 2026-06-30 |
| 22 | — | Zura Bio Ltd | 450.0K | $2.7M | $2.7M | 0.52% | -- | 2026-06-30 |
| 23 | KLRA | Kailera Therapeutics, Inc. | 37.5K | $826K | $479K | 0.09% | -- | 2026-06-30 |
| 24 | IRON | Disc Medicine, Inc. | 970 | $70K | $74K | 0.01% | -- | 2026-06-30 |
← Scroll →